Skip to main content
Premium Trial:

Request an Annual Quote

Lion, Silicon Genetics to Integrate Software

NEW YORK, June 3 - Silicon Genetics and Lion Bioscience said today that they have begun a multi-year joint development and marketing collaboration centered around the integration of their software products: Silicon Genetics' GeneSpring and Lion's SRS and Target Engine.

 

Initially, the integration will allow users of the GeneSpring gene expression analysis platform to access data stored in Lion's SRS integration platform. This will allow scientists to include information from both public and proprietary sources in their gene expression analysis, the companies said.

 

Lion will also integrate GeneSpring software with its upcoming Target Engine drug discovery software platform, and will be able to co-market GeneSpring along with SRS and Target Engine.

 

Click here to see the full announcement.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.